16 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32221318 | Nanosized Alumina Particle and Proteasome Inhibitor Bortezomib Prevented inflammation and Osteolysis Induced by Titanium Particle via Autophagy and NF-κB Signaling. | 2020 Mar 27 | 1 |
2 | 30914235 | Inhibitory effects of bortezomib in a subcutaneous tumor model of H22 mouse hepatocarcinoma cells. | 2019 Jun | 1 |
3 | 29773987 | Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma. | 2018 | 1 |
4 | 28487944 | Bortezomib protects against dextran sulfate sodium‑induced ulcerative colitis in mice. | 2017 Jun | 1 |
5 | 28800777 | Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity. | 2017 Aug 11 | 1 |
6 | 24406455 | Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model. | 2014 Mar | 3 |
7 | 24530998 | TNF-α-mediated JNK activation in the dorsal root ganglion neurons contributes to Bortezomib-induced peripheral neuropathy. | 2014 May | 4 |
8 | 24022788 | Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target. | 2013 Dec | 1 |
9 | 22427154 | Inhibition of titanium particle-induced inflammation by the proteasome inhibitor bortezomib in murine macrophage-like RAW 264.7 cells. | 2012 Aug | 1 |
10 | 21360496 | Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis. | 2011 Mar | 1 |
11 | 18539902 | Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation. | 2008 Aug 15 | 1 |
12 | 17328981 | Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib. | 2007 May | 1 |
13 | 17373661 | TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response. | 2007 Jul 15 | 6 |
14 | 16397116 | Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells. | 2006 Apr | 1 |
15 | 16585569 | Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade). | 2006 Apr 15 | 1 |
16 | 16670342 | Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors. | 2006 May 15 | 4 |